Spotlight Growth
No Result
View All Result
Saturday, March 25, 2023
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener
No Result
View All Result
No Result
View All Result
Home Technology

Pulse Evolution Corp. (OTC Pink: PLFX) Surges 68.18% After EvolutionAI Corporation Offers To Purchase Unrestricted, “Public Float” Shares At $1.10 Per Share

by admin
February 9, 2018
in Technology
0
Digital Humans Technology Accredited Investor Offering

Digital Humans Technology Accredited Investor Offering

Pulse Evolution Corp. (OTC Pink: PLFX) is engaged within the development of virtual human likeness technologies, which create hyper-realistic digital humans. Shares of the technology company are soaring 68.18%, through early trading on Friday, February 9, 2018. Over the past month, Pulse Evolution Corp. has seen average daily volume of 33,342 shares. However, volume of 256,478 shares or dollar volume of $51,295, has already exchanged hands on the day.

Shares of Pulse Evolution Corp. are surging today, after the company received an offer from EvolutionAI Corporation to purchase any or all unrestricted and free-trading common shares of PLFX from accredited investors only. The proposed share purchase will be conducted through a registered share exchange at a price of $1.10 per share of PLFX. Individual accredited investors hold around 119 million common shares of Pulse Evolution Corp., and have already begun the necessary paperwork for the share exchange. Here is the full press release detailing of the share exchange agreement:

Pulse Evolution Corp. Press Release:

HOBE SOUND, Fla., Feb. 8, 2018 /PRNewswire/ — Evolution|AI Corporation today unveiled specific pricing and structural elements of its Offer to purchase, from accredited investors only, all or any portion of the unrestricted, free-trading common shares of Pulse Evolution Corporation (OTC:PLFX) common stock, currently on deposit in the ‘public float’, through a registered share exchange for $1.10 per share.

Evolution|AI Corporation (the “Company”) also provided today an update relating to its prior offer to purchase restricted shares in a transaction value at $0.62 per share.  Pulse Acquisition Corporation (“PAC”) was created by the principals of Evolution|AI, to consolidate the restricted shares of parties that responded favorably to the Company’s October 2017 offer.  Since then, individual accredited investors, holding approximately 119 million common shares of Pulse in the aggregate, have entered into the process of documenting and closing the restricted share exchange.  The exchange transaction, representing at least a majority interest in Pulse, is expected to close on, or before February 28, 2018.

Evolution|AI Corporation now, directly for its own account, wishes to acquire up to 14 million shares of unrestricted, fully registered common stock, of which the Company believes approximately 8 million shares are currently on deposit with brokerage firms in the public float.  The basic terms of the current offer (the “Registered Exchange”) are as follows:

  1.  Participating Pulse shareholders, who are accredited investors, shall be entitled to exchange their unrestricted, common   shares for fully registered shares in the Company, at their election, through either of two exchange structures, as follows:
    • $1.10 per share shall be paid, in the form of fully registered shares of the Company, to those participating Pulse shareholders who agree to an ‘irrevocable’ share exchange agreement, with such share exchange subject to the effectiveness of the Company’s registration statement (the “Registration Statement”), to be filed with the SEC, specifically for the purpose of delivering the consideration of the transaction;
    • $0.78 per share shall be paid, in the form of fully registered shares of the Company, to those participating Pulse shareholders who agree to a ‘revocable’ share exchange agreement, similar in all respects to the irrevocable exchange, though it may be cancelled at the election of the Pulse shareholder, at any time prior to the effectiveness of the Registration Statement, if the average closing price of PLFX common stock, for any 5-day trading period, exceeds $0.78 per share;
    • The Exchange Transaction consideration will be paid in the form of fully registered shares of the Company, based on the same manner of valuation of Company shares as utilized in the arms-length transactions between Pulse shareholders and PAC’s pending acquisition of restricted shares at $0.62 per share. Notwithstanding the initial share exchange ratio, structured to deliver the share price consideration of 1(a) and 1(b) above, in the event the 10-day average market value of Company shares is less than $1.10 per share, as required by 1(a), or $0.78 per share, as required by 1(b), at the later of (i) a date which is 60 days after the date of effectiveness of the Company’s first registration statement filed with the SEC, or (ii) 30 days after the commencement of trading of the Company’s shares, the Company shall issue additional shares to the Pulse shareholders, up to 200% of the initial share issuance, as necessary to deliver the target valuation of the Exchange Transaction.  In such event, if the maximum number of additional shares is still not sufficient to deliver the target share valuations or either $1.10 per share, or $0.78 per share, as the case may be, then the respective Pulse shareholders may elect to either unwind the Exchange Transaction or require such consideration to be paid by the Company in cash.

Accredited Investors who are holders of common stock of Pulse Evolution Corporation, if interested in the above outlined offer, are encouraged to contact the Company directly via Offer@EvolutionAI.com. This Offer to Purchase shall remain outstanding until its expiration at 5:00pm on Wednesday, February 28, 2018.

About Evolution|AI Corporation

Evolution|AI Corporation is a development stage company focused on the adaptation and development of human animation technology to enable diverse Artificial Intelligence platforms to interact with consumers in the relatable form of a human face. Founded by Mr. John Textor, an established and globally recognized pioneer in the field of hyper-realistic human animation, Evolution|AI intends to develop a robust library of fully functional human faces, and human characters, that will allow people to communicate with leading artificial intelligence platforms, just as they would expect to communicate with another human being.

Evolution|AI, which is also a licensee of Pulse Evolution technology, recently acquired a robust portfolio of technology, acquired from the legendary visual effects company Digital Domain, representing substantially all of the technology developed in connection with launch and operation of Digital Domain’s Florida animation studio.  With the benefit of both the Digital Domain animation and studio technology portfolio, and the market leading human animation technology licensed from Pulse Evolution Corporation, Evolution|AI is uniquely positioned to be a true pioneer in the globally significant industry that emerging through the deployment of artificially intelligent digital humans in society, commerce and education.

Tags: accredited investorsacquisitionAIArtificial Intelligencecommon stockcomputer generated imagesdigital humansdigital softwareemerging growthinvestmentMergermicrocap stocksofferingpublic companysmall cap companiessmall cap stockssmall capsSpotlight GrowthSpotlight Growth StockstechTechnologytechnology stocksvirtual reality
  • Trending
  • Comments
  • Latest
Asure Software NASDAQ ASUR Human Capital Management HCM Industry Spotlight Growth

Asure Software (NASDAQ: ASUR) is Expanding to Meet the Rising Demand for Human Capital Management Software

September 27, 2022
OLB Group NASDAQ OLB Cuentas NASDAQ CUEN Partnership Fintech Spotlight Growth

OLB Group (NASDAQ: OLB) and Cuentas (NASDAQ: CUEN) Team Up to Bring Fintech Solutions to Over 32,000 Bodegas Across the United States

October 6, 2022
Siyata Mobile NASDAQ SYTA SYTAW SD7 VK7 Purchase Orders Spotlight Growth

New Purchase Orders for SD7 Rugged Device, VK7, and Other Accessories Boost Siyata Mobile’s Outlook (NASDAQ: SYTA)

December 14, 2021
Telcoin TEL Crypto Spotlight Growth

Telcoin (TEL) Quietly Leads a Crypto Remittance Revolution

June 15, 2021
Cybersecurity Stocks Coming Into Focus Amid High-Profile Attacks

Cybersecurity Stocks Coming Into Focus Amid High-Profile Attacks

0
Safe-T SFET NASDAQ UN Presentation

Safe-T (NASDAQ: SFET) Has Been Selected to Present at the United Nations’ Office of Information and Communications Technology Event

0
Safe-T Group SFET Q4 FY 2020 Financial Results

Safe-T Group (NASDAQ: SFET) Reports Fourth Quarter and Full Year 2020 Financial Results

0
Safe-T Group NASDAQ SFET FY 2020 Prelim

Safe-T Group Ltd. (NASDAQ: SFET) Estimates Record-High Annual Revenues of Approximately $4.9 Million Representing ~50% Growth YoY 2020

0
Is U.S. Government Trying to Ban Crypto Spotlight Growth

Is The U.S. Government Trying to Ban Crypto?

March 23, 2023
Bioadaptives OTC Pink BDPT LOI World Wellness Health and Wellness Spotlight Growth

Bioadaptives (OTC Pink: BDPT) Signs LOI with World Wellness, LLC to Develop New Health and Wellness Products

March 23, 2023
JanOne NASDAQ JAN Sells ARCA Recycling Business Focus on Biopharma Spotlight Growth

JanOne (NASDAQ: JAN) Sells ARCA Recycling Business to VM7, Will Focus on Budding Biopharmaceuticals Business

March 22, 2023
89bio NASDAQ ETNB Phase 2b ENLIVEN Trial Pegozafermin NASH Spotlight Growth

89bio (NASDAQ: ETNB) Reports Phase 2b ENLIVEN Trial of Pegozafermin Achieved Primary Endpoints For Treatment of Nonalcoholic Steatohepatitis (NASH)

March 22, 2023

Recent News

Is U.S. Government Trying to Ban Crypto Spotlight Growth

Is The U.S. Government Trying to Ban Crypto?

March 23, 2023
Bioadaptives OTC Pink BDPT LOI World Wellness Health and Wellness Spotlight Growth

Bioadaptives (OTC Pink: BDPT) Signs LOI with World Wellness, LLC to Develop New Health and Wellness Products

March 23, 2023

Categories

  • Bio/Med/Pharma
  • Cannabis
  • Commodities
  • Consumer Goods
  • Crowdfunding
  • Crypto Cheat Sheets
  • Cryptocurrency
  • Earnings
  • Education
  • Entertainment
  • Financials
  • Market News
  • Opinion
  • Politics
  • Real Estate
  • Split Watch
  • Sponsored
  • Store
  • Technology
  • Uncategorized
  • Venture Capital/Private Equity (VC/PE)

Site Navigation

  • Disclosures
  • Terms Of Service
  • Privacy Policy
  • Contact Us

Copyright © 2017-2022 Spotlight Growth. All Right Reserved. Designed by Cool Cat Interactive.

No Result
View All Result
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener

Copyright © 2017-2022 Spotlight Growth. All Right Reserved. Designed by Cool Cat Interactive.

Newsletter Signup

Subscribe to our weekly newsletter below and never miss the latest small/micro-cap analysis and investment news from Spotlight Growth.

Enter your email address

Thanks, I’m not interested